CWAM
WX

Columbia Wanger Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Columbia Wanger Asset Management’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-578,000
Closed -$25M – 193
2015
Q3 		$25M Sell
578,000
-435,906
-43% -$18.4M 0.2% 155
2015
Q2 		$42.8M Sell
1,013,906
-133,094
-12% -$5.61M 0.28% 135
2015
Q1 		$44.5M Sell
1,147,000
-2,187,742
-66% -$84.3M 0.24% 148
2014
Q4 		$112M Sell
3,334,742
-13,278
-0.4% -$469K 0.56% 55
2014
Q3 		$117M Sell
3,348,020
-13,121
-0.4% -$450K 0.54% 54
2014
Q2 		$110M Buy
3,361,141
+26,241
+0.8% +$898K 0.44% 72
2014
Q1 		$123M Buy
3,334,900
+351,023
+12% +$12.9M 0.48% 61
2013
Q4 		$115M Sell
2,983,877
-18,488
-0.6% -$584K 0.44% 73
2013
Q3 		$82.3M Buy
3,002,365
+293,888
+11% +$6.96M 0.33% 106
2013
Q2 		$56.9M Buy
+2,708,477
New +$52.9M 0.25% 148

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Columbia Wanger Asset Management's WX Position: Q4 2015 in Review

Columbia Wanger Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 578,000 shares — an estimated $25M sold.

Columbia Wanger Asset Management first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $123M in Q1 2014. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Columbia Wanger Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Columbia Wanger Asset Management sold 578,000 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $25M.
  • Columbia Wanger Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • Columbia Wanger Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $123M in Q1 2014.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2015, filed 8 Feb 2016.